John M. Stamm

506 total citations
21 papers, 402 citations indexed

About

John M. Stamm is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, John M. Stamm has authored 21 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Molecular Medicine and 3 papers in Infectious Diseases. Recurrent topics in John M. Stamm's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). John M. Stamm is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). John M. Stamm collaborates with scholars based in United States, United Kingdom and Netherlands. John M. Stamm's co-authors include Prabhavathi Fernandes, C W Hanson, N. L. Shipkowitz, D. T. W. CHU, Robert R. Bower, James E. Parsons, Robert T. Bailer, N Ramer, R. N. Swanson and Dwight J. Hardy and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Hazardous Materials and The American Journal of Medicine.

In The Last Decade

John M. Stamm

19 papers receiving 336 citations

Peers

John M. Stamm

PHARM

POLLU

IMMUN

Prem S. Jaglan United States

G Mengozzi Italy

A. Markus Germany

R. N. Jones United States

P. Bringas Spain

Ian F. Moore Canada

Barbara J. Kamicker United States

Ronald J. Ash United States

Saswati Sengupta India

Paula Amador Portugal

Prem S. Jaglan United States

John M. Stamm

209 ×0.9

PHARM

133 ×0.9

109 ×0.8

POLLU

57 ×0.7

13 ×0.2

IMMUN

Citations per year, relative to John M. Stamm John M. Stamm (= 1×) peers Prem S. Jaglan

Countries citing papers authored by John M. Stamm

Since Specialization

Citations

This map shows the geographic impact of John M. Stamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Stamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Stamm more than expected).

Fields of papers citing papers by John M. Stamm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Stamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Stamm. The network helps show where John M. Stamm may publish in the future.

Co-authorship network of co-authors of John M. Stamm

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Stamm. A scholar is included among the top collaborators of John M. Stamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Stamm. John M. Stamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stamm, John M., et al.. (2000). Biodegradation of 14 C-Sarafloxacin Hydrochloride, A Fluoroquinolone Antimicrobial by Phanerochaete Chrysosporiumt. 4 indexed citations

Stamm, John M., et al.. (1997). Aerobic biodegradation of (14C)-sarafloxacin hydrochloride in soil. Environmental Toxicology and Chemistry. 16(3). 462–471. 75 indexed citations

O’Brien, Kelly K., et al.. (1997). AEROBIC BIODEGRADATION OF (14C)-SARAFLOXACIN HYDROCHLORIDE IN SOIL. Environmental Toxicology and Chemistry. 16(3). 462–462. 9 indexed citations

Dijkstra, J.W., et al.. (1995). Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. Veterinary Quarterly. 17(1). 1–5. 11 indexed citations

Lightner, Donald V., et al.. (1995). Evaluation of Difloxacin for Shrimp Aquaculture: In Vitro Minimum Inhibitory Concentrations, Medicated Feed Palatability, and Toxicity to the ShrimpPenaeus vannamei. Journal of Aquatic Animal Health. 7(2). 161–167. 3 indexed citations

Lightner, Donald V., et al.. (1994). Preliminary studies on the palatability, animal safety, and tissue residues of sarafloxacin-HCl in the penaeid shrimp, Penaeus vannamei. Aquaculture. 126(3-4). 231–241. 6 indexed citations

Stamm, John M., et al.. (1993). Selection of field and laboratory studies for environmental assessment. Journal of Hazardous Materials. 35(2). 313–329. 1 indexed citations

Stamm, John M., et al.. (1993). The synthesis of new acridinium salt aquatic antifungals. Tetrahedron Letters. 34(45). 7161–7162. 2 indexed citations

Stamm, John M.. (1989). In Vitro Resistance by Fish Pathogens to Aquacultural Antibacterials, Including the Quinolones Difloxacin (A-56619) and Sarafloxacin (A-56620). Journal of Aquatic Animal Health. 1(2). 135–141. 69 indexed citations

10.

Fernandes, Prabhavathi, D. T. W. CHU, R. N. Swanson, et al.. (1988). A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 32(1). 27–32. 26 indexed citations

11.

Fernandes, Prabhavathi, et al.. (1987). The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo. Journal of Antimicrobial Chemotherapy. 19(4). 449–465. 32 indexed citations

12.

Stamm, John M., et al.. (1986). In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy. 29(2). 193–200. 48 indexed citations

13.

Stamm, John M.. (1984). Cefmenoxime: In Vitro Activity. The American Journal of Medicine. 77(6). 1–3. 11 indexed citations

14.

Stamm, John M., et al.. (1981). Antimicrobial Activity of Cefmenoxime (SCE-1365). Antimicrobial Agents and Chemotherapy. 19(3). 454–460. 27 indexed citations

15.

Sell, Sarah H., et al.. (1978). Treatment of Otitis Media Caused by Hemophilus influenzae: Evaluation of Three Antimicrobial Regimens. Southern Medical Journal. 71(12). 1493–1497. 8 indexed citations

16.

Stamm, John M., et al.. (1977). Fortimicins A and B, new aminoglycoside antibiotics. IV. in vitro Study of fortimicin a compared with other aminoglycosides.. The Journal of Antibiotics. 30(7). 564–570. 32 indexed citations

17.

Stamm, John M., et al.. (1976). Inhibitory Effect of Light on Growth-Supporting Properties of Eosin Methylene Blue Agar. Applied and Environmental Microbiology. 31(1). 141–142. 2 indexed citations

18.

Stamm, John M.. (1969). Microbiological Study ofWater-Softener Resins.

19.

Stamm, John M., et al.. (1969). Microbiological Study of Water-Softener Resins. Applied Microbiology. 18(3). 376–386. 21 indexed citations

20.

Stamm, John M., et al.. (1969). Microbiological Study of Water-Softener Resins. Applied Microbiology. 18(3). 376–386. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact